Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Sufentanil for Acute Pain in Ambulatory Surgery
NCT04387136Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Oct 2020
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sufentanil in acute pain, sponsored by University of Minnesota. Started Oct 2020; status: completed.
02
Drugs
sufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04387136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387136.